Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Everolimus Plus Exemestane Treatment in Metastatic Hormone Receptor-Positive Breast Cancer Patients Previously Treated With CDK4/6 Inhibitor TherapyOncologist 2020 Nov 23;[EPub Ahead of Print], MM Cook, LA Rabadi, AJ Kaempf, MM Saraceni, MA Savin, ZI Mitri
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.